Multiomic characterization of disease progression in mice lacking dystrophin
PLOS ONE · 31.03.2023 · 18 (3) · e0283869
DOI: 10.1371/journal.pone.0283869 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 31.03.2023. Verfasst von Mirko Signorelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mathematical Institute, Leiden University, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Dystrophin, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Duchenne Parent Project.
Abstract (Originalsprache)
Duchenne muscular dystrophy (DMD) is caused by genetic mutations leading to lack of dystrophin in skeletal muscle. A better understanding of how objective biomarkers for DMD vary across subjects and over time is needed to model disease progression and response to therapy more effectively, both in pre-clinical and clinical research. We present an in-depth characterization of disease progression in 3 murine models of DMD by multiomic analysis of longitudinal trajectories between 6 and 30 weeks of age. Integration of RNA-seq, mass spectrometry-based metabolomic and lipidomic data obtained in muscle and blood samples by Multi-Omics Factor Analysis (MOFA) led to the identification of 8 latent factors that explained 78.8% of the variance in the multiomic dataset. Latent factors could discriminate dystrophic and healthy mice, as well as different time-points. MOFA enabled to connect the gene expression signature in dystrophic muscles, characterized by pro-fibrotic and energy metabolism alterations, to inflammation and lipid signatures in blood. Our results show that omic observations in blood can be directly related to skeletal muscle pathology in dystrophic muscle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mathematical Institute, Leiden University, Leiden, The Netherlands.
- Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Mirko Signorelli, Annemieke Aartsma-Rus, Pietro Spitali
Förderung
- Duchenne Parent Project
Zitieren
APA
Signorelli, M., Tsonaka, R., Aartsma-Rus, A., & Spitali, P. (2023). Multiomic characterization of disease progression in mice lacking dystrophin. PLOS ONE, 18(3), e0283869. https://doi.org/10.1371/journal.pone.0283869
Vancouver
Signorelli M, Tsonaka R, Aartsma-Rus A, Spitali P. Multiomic characterization of disease progression in mice lacking dystrophin. PLOS ONE. 2023;18(3):e0283869. doi:10.1371/journal.pone.0283869
BibTeX
@article{Signorelli2023,
author = {Signorelli, Mirko and Tsonaka, Roula and Aartsma-Rus, Annemieke and Spitali, Pietro},
title = {Multiomic characterization of disease progression in mice lacking dystrophin},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {3},
pages = {e0283869},
doi = {10.1371/journal.pone.0283869}
}
EUVIMED